drugset / Trial / NCT03376594
Benjakul Extract and Loratadine for Treatment Allergic Rhinitis Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
1. To compare the effectiveness of Benjakul extract capsules at 300 mg per day with Loratadine drug in the treatment of allergic rhinitis patients in small group (Clinical Trial Phase II). 2. To study the safety and side effects of Benjakul extract capsules 300 mg per day and Loratadine drug for allergic rhinitis patients.
Timeline
- Start
- 2017-07-30
- Primary completion
- 2018-02-01
- Completion
- 2018-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Benjakul Extract | Unknown | 100 mg | Oral |
| Comparator | Loratadine | Small molecule | 10 mg | Oral |